Hemostat Powder Market, Global Outlook and Forecast 2023-2029

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.
This report aims to provide a comprehensive presentation of the global market for Hemostat Powder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostat Powder. This report contains market size and forecasts of Hemostat Powder in global, including the following market information:
Global Hemostat Powder Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hemostat Powder Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Hemostat Powder companies in 2022 (%)
The global Hemostat Powder market was valued at US$ 397.6 million in 2022 and is projected to reach US$ 537.5 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.
North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.
Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 65%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemostat Powder manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemostat Powder Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Hemostat Powder Market Segment Percentages, by Type, 2022 (%)
    Gelatin
    Fibrin
    Cellulose
    Others
Global Hemostat Powder Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Hemostat Powder Market Segment Percentages, by Application, 2022 (%)
    Surgical Wound Care
    General Wound Care
Global Hemostat Powder Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Hemostat Powder Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemostat Powder revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hemostat Powder revenues share in global market, 2022 (%)
Key companies Hemostat Powder sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Hemostat Powder sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Johnson & Johnson
    C. R. Bard
    Pfizer
    CSL Behring
    Gelita Medical
    Ferrosan Medical Devices
    Baxter
    Celox
    Equimedical
    Medira
    Biocer
    Hemostasis
    MBP
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemostat Powder, market overview.
Chapter 2: Global Hemostat Powder market size in revenue and volume.
Chapter 3: Detailed analysis of Hemostat Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemostat Powder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hemostat Powder capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.